Kellanova (formerly Kellogg Company) is engaged in the manufacture and marketing of snacks and convenience foods. The company produces a variety of products including snacks like crackers, savory snacks, toaster pastries, cereal bars, granola bars, and bites, as well as convenience foods such as ready-to-eat cereals, frozen waffles, veggie foods, and noodles. The company's snack brands are marketed under names such as Kellogg’s, Eggo and Morningstar Farms, Cheez-It, Pringles, Austin, Parati, and RXBAR. The company sells its products to retailers and other customers through direct sales forces and uses broker and distributor arrangements for certain products and channels.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Kellanova's R&D arm focuses on expanding the use of existing products and to develop new food products. The company's R&D efforts include new product and process innovation, as well as significant technological improvements to existing products and processes. The R&D unit of the company is the W. K. Kellogg Institute for Food and Nutrition Research located in Battle Creek, Michigan, the US. In FY2024, the company incurred an expense of US$115 million on R&D, which as a percentage of revenue, stood at 0.9%.